The Role of the Microbiome in Women’s Hormonal Health
August 29, 2024
We ensure our content is always unique, unbiased, supported by evidence. Each piece is based on a review of research available at the time of publication and is fact-checked and medically reviewed by a topic expert.
Written by: Kyla Reda
Medically reviewed by: Lara Zakaria PharmD, CNS, IFMCP
The human microbiome is a complex community of microorganisms living in and on our bodies, which plays a crucial role in maintaining women’s hormone health. Understanding this intricate relationship can help you better address and manage hormonal imbalances in your patients.
In women, the microbiome affects everything from hormone levels to menstrual and reproductive health.
The gut microbiome is integral to hormone regulation. It helps metabolize and modulate hormones, such as estrogen, through the production of enzymes. For example, certain gut bacteria produce beta-glucuronidase, an enzyme that affects estrogen recycling in the body. An imbalance in these bacteria can lead to either an excess or deficiency of estrogen, which can cause estrogen-related diseases like gynecological cancers and menopausal syndrome. (Hu 2023)
A balanced microbiome supports regular menstrual cycles by maintaining optimal hormone levels and reducing inflammation. Dysbiosis, an imbalance in the microbiome, can lead to irregular periods, premenstrual syndrome (PMS), and even conditions like polycystic ovary syndrome (PCOS). (Siddiqui 2022)
Experiencing PMS or irregular periods could be due to an imbalanced gut or vaginal microbiome.
The vaginal microbiome is crucial for reproductive health, producing lactic acid, which inhibits the growth of yeast, bacteria, and viruses, and supporting healthy pregnancy. (Elkafas 2022) Imbalances in the vaginal microbiome can cause conditions like bacterial vaginosis (BV), which is linked to preterm labor, early and late miscarriage, postabortal sepsis (chills, fever, rapid heart rate, and vaginal bleeding after an abortion), and other pregnancy complications. In women who aren't pregnant, BV has been linked to a greater risk of upper genital tract or sexually transmitted infections. (Lamont 2011)
Dysbiosis is a disruption in the balance of the microbiome, which can have significant effects on hormonal health. Dysbiosis can be caused by lifestyle factors like poor diet, stress, antibiotic use, and environmental toxins. (Malesza 2021) (McDonnell 2021) (Rosenfeld 2017) (Szczuko 2021) This imbalance can disrupt normal hormonal function, leading to a range of symptoms and conditions. (Elkafas 2022)
Symptoms of microbiome-related hormonal imbalances can include:
Numerous conditions involving hormonal imbalance have been associated with an imbalanced microbiome. Some of the most common examples are listed below.
Emerging research suggests that dysbiosis may play a role in the development and progression of endometriosis, a condition characterized by the growth of endometrial tissue outside the uterus. 30–50% of endometriosis patients struggle with infertility, showing that dysbiosis can directly affect reproductive health through this condition. (Zizolfi 2023)
Dysbiosis has been linked to a number of reproductive issues in women, including infertility and endometriosis.
Both gut and vaginal microbiome imbalances can impact fertility by affecting hormone levels and increasing the risk of infections that compromise reproductive health. (Venneri 2022)
Dysbiosis is often observed in women with PCOS, contributing to hormonal imbalances that affect ovulation and increase androgen levels. (Zhu 2022)
Imbalances in the gut microbiome can exacerbate symptoms of PMS, such as mood swings, bloating, and cramps. One study found that quantities of certain bacteria were significantly higher in women with PMS, particularly Collinsella, whose numbers are affected by diet. (Okuma 2022)
Microbiome testing is an essential tool for understanding and managing hormonal imbalances. By analyzing the composition and diversity of the gut and vaginal microbiomes, healthcare providers can identify imbalances and personalize interventions to restore microbial harmony. Testing can provide insights into a patient’s metabolic activity and bacterial diversity, by identifying beneficial and harmful bacteria levels. It can also help detect inflammatory markers that indicate inflammation or dysbiosis.
Stool testing offered by various specialty lab companies offers a comprehensive analysis of gut health. As part of the evaluation, we’re able to measure beta-glucuronidase, an enzyme linked to estrogen recycling in the body, which can impact estrogen dominance—a common concern in conditions like PMS, endometriosis, and breast cancer. (Hu 2023) Stool testing also provides insights into gut inflammation, digestive efficiency, and short-chain fatty acid production, which are crucial for maintaining a healthy microbiome and supporting hormone regulation.
Overall, it’s evident that the human microbiome plays a major role in women’s hormone health. Understanding and supporting the microbiome can lead to significant improvements in women's health, promoting balanced hormones, regular menstrual cycles, and overall reproductive well-being. Microbiome testing offers a helpful tool for personalizing patient treatment strategies and achieving better health outcomes.
References
De Pessemier, B., Grine, L., Debaere, M., Maes, A., Paetzold, B., & Callewaert, C. (2021). Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms, 9(2), 353. https://doi.org/10.3390/microorganisms9020353
Elkafas, H., Wall, M., Al-Hendy, A., & Ismail, N. (2022). Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.1059825
Gomes, A. C., Hoffmann, C., & Mota, J. F. (2018). The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes, 1–18. https://doi.org/10.1080/19490976.2018.1465157
Hu, S., Ding, Q., Zhang, W., Kang, M., Ma, J., & Zhao, L. (2023). Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes, 15(1). https://doi.org/10.1080/19490976.2023.2236749
Lamont, R., Sobel, J., Akins, R., Hassan, S., Chaiworapongsa, T., Kusanovic, J., & Romero, R. (2011). The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG, 118(5), 533–549. https://doi.org/10.1111/j.1471-0528.2010.02840.x
Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., & Yin, Y. (2021). Gut Microbiota and diarrhea: An updated review. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.625210
Malesza, I. J., Malesza, M., Walkowiak, J., Mussin, N., Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J., & Mądry, E. (2021). High-Fat, Western-Style diet, systemic inflammation, and gut microbiota: A Narrative review. Cells, 10(11), 3164. https://doi.org/10.3390/cells10113164
McDonnell, L., Gilkes, A., Ashworth, M., Rowland, V., Harries, T. H., Armstrong, D., & White, P. (2021). Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes, 13(1). https://doi.org/10.1080/19490976.2020.1870402
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., Ramanathan, G., C, G. P. D., Elsherbiny, N., Elsherbini, A. M., Alsamman, A. M., Zayed, H., & Gopalakrishnan, A. V. (2023). The implication of mechanistic approaches and the role of the microbiome in polycystic ovary Syndrome (PCOS): a review. Metabolites, 13(1), 129. https://doi.org/10.3390/metabo13010129
Okuma, K., Kono, K., Otaka, M., Ebara, A., Odachi, A., Tokuno, H., & Masuyama, H. (2022). Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome. International Journal of Women’s Health, Volume 14, 1435–1445. https://doi.org/10.2147/ijwh.s377066
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M., Licinio, J., & Wesselingh, S. (2016). From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular Psychiatry, 21(6), 738–748. https://doi.org/10.1038/mp.2016.50
Rosenfeld, C. S. (2017). Gut dysbiosis in animals due to environmental chemical exposures. Frontiers in Cellular and Infection Microbiology, 7. https://doi.org/10.3389/fcimb.2017.00396
Siddiqui, R., Makhlouf, Z., Alharbi, A. M., Alfahemi, H., & Khan, N. A. (2022). The gut microbiome and female health. Biology, 11(11), 1683. https://doi.org/10.3390/biology11111683
Szczuko, M., Kikut, J., Szczuko, U., Szydłowska, I., Nawrocka-Rutkowska, J., Ziętek, M., Verbanac, D., & Saso, L. (2021). Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review. Nutrients, 13(7), 2452. https://doi.org/10.3390/nu13072452
Venneri, M. A., Franceschini, E., Sciarra, F., Rosato, E., D’Ettorre, G., & Lenzi, A. (2022). Human genital tracts microbiota: dysbiosis crucial for infertility. Journal of Endocrinological Investigation, 45(6), 1151–1160. https://doi.org/10.1007/s40618-022-01752-3
Zhu, W., Fu, L., Xu, C., Peng, K., Liu, Y., Tang, H., Huang, Y., & Yang, X. (2022). Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.978019
Zizolfi, B., Foreste, V., Gallo, A., Martone, S., Giampaolino, P., & Di Spiezio Sardo, A. (2023). Endometriosis and dysbiosis: State of art. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1140774